What you might want to know: – Eli Lilly’s Kisunla™ (donanemab-azbt) has been authorized by the FDA as a therapy for adults with early-stage Alzheimer’s illness (AD), together with these with gentle cognitive impairment (MCI) and gentle dementia, who’ve confirmed amyloid plaque formation within the mind. – The FDA’s approval marks a serious step ahead within the battle in opposition […]
